Mabthera and progressive multifocal leukoencephalopathy Patient Reports March 18, 2010



Mabthera Side Effects Report #5966024-8
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 10, 2008. Male patient, 78 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5619200-8
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Dec 05, 2007. Female patient, 70 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aphasia What is  aphasia, cerebrovascular accident, hemiplegia, hypoaesthesia, progressive multifocal leukoencephalopathy, status epilepticus. Mabthera dosage: 375 MG, 1/WEEK. During the same period patient was treated with CHLORAMBUCIL, FLUDARABINE, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #5626749-0
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Feb 06, 2008. Female patient, 70 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aphasia What is  aphasia, cerebrovascular accident, hemiplegia, hypoaesthesia, progressive multifocal leukoencephalopathy, status epilepticus. Mabthera dosage: unknown. During the same period patient was treated with CHLORAMBUCIL, FLUDARA, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #5690953-6
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Mar 24, 2008. Female patient, 70 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aphasia What is  aphasia, cerebrovascular accident, hemiplegia, hypoaesthesia, progressive multifocal leukoencephalopathy, status epilepticus. Mabthera dosage: unknown. During the same period patient was treated with CHLORAMBUCIL, FLUDARABINE, CYCLOPHOSPHAMIDE. Patient recovered.


Mabthera Side Effects Report #5915304-0
Mabthera side effect was reported by a Physician from AUSTRALIA on Oct 02, 2008. Male patient, 64 years of age, was diagnosed with waldenstrom's macroglobulinaemia, hyperviscosity syndrome and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pancytopenia, pneumonia What is  pneumonia, progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, PREDNISOLONE, MITOXANTRONE, FLUDARABINE PHOSPHATE, WARFARIN, CLOPIDOGREL, THALIDOMIDE. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #5605108-0
Mabthera side effect was reported by a Physician from FRANCE on Jan 15, 2008. Female patient, weighting 121.3 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with IMMUNOSUPPRESSANTS, CORTICOSTEROIDS, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, CHLORAMINOPHENE. Patient died on 07/15/2007.

Mabthera Side Effects Report #5690922-6
Mabthera side effect was reported by a Physician from FRANCE on Mar 24, 2008. Female patient, weighting 121.3 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aphasia What is  aphasia, cerebrovascular accident, hemiplegia, hypoaesthesia, progressive multifocal leukoencephalopathy, status epilepticus. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with IMMUNOSUPPRESSANTS, CYCLOPHOSPHAMIDE. Patient died on 07/15/2007.

Mabthera Side Effects Report #5280406-1
Mabthera side effect was reported by a Physician from SWEDEN on Mar 10, 2007. Female patient, child 1 years of age, was diagnosed with vasculitis What is  vasculitis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-lymphocyte count decreased, cognitive disorder, diplopia, jc virus infection, leg amputation, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5268672-X
Mabthera side effect was reported by a Physician from SWEDEN on Feb 26, 2007. Female patient, child -1 years of age, was diagnosed with vasculitis What is  vasculitis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, no therapeutic response, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2, UNK. Patient recovered.


Mabthera Side Effects Report #5299894-X
Mabthera side effect was reported by a Physician from SWEDEN on Mar 29, 2007. Female patient was diagnosed with vasculitis What is  vasculitis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cognitive disorder, cryoglobulins present, diplopia, foot amputation, jc virus infection, no therapeutic response, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2, UNK. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.

Mabthera Side Effects Report #5344361-8
Mabthera side effect was reported by a Physician from UNITED STATES on May 24, 2007. Female patient was diagnosed with vasculitis What is  vasculitis, pain What is  pain and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cognitive disorder, diplopia, disease progression, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.

Mabthera Side Effects Report #5866006-0
Mabthera side effect was reported by a Physician from UNITED STATES on Aug 21, 2008. Female patient was diagnosed with vasculitis What is  vasculitis, pain What is  pain and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cognitive disorder, diplopia, disease progression, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.

Mabthera Side Effects Report #5914990-9
Mabthera side effect was reported by a Physician from ITALY on Oct 02, 2008. Female patient was diagnosed with vasculitis What is  vasculitis, pain What is  pain and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cognitive disorder, diplopia, disease progression, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.

Mabthera Side Effects Report #5090846-1
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Aug 10, 2006. Female patient was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-lymphocyte count decreased, hiv infection What is  hiv infection, jc virus infection, lumbar puncture abnormal, pneumonia aspiration, progressive multifocal leukoencephalopathy. Mabthera dosage: 325 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with AMLODIPINE BESYLATE, CALCICHEW D, HYDROXYCHLOROQUINE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.


Mabthera Side Effects Report #5579736-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 27, 2007. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.

Mabthera Side Effects Report #5589560-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 07, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, b-lymphocyte count decreased, disease recurrence, herpes zoster, intestinal obstruction, pneumonia aspiration, post procedural pneumonia, progressive multifocal leukoencephalopathy, respiratory failure. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.

Mabthera Side Effects Report #5664852-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 07, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.

Mabthera Side Effects Report #5695032-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 25, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow toxicity, progressive multifocal leukoencephalopathy, respiratory failure. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.

Mabthera Side Effects Report #5705161-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy, respiratory failure. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, CORTICOSTEROIDS, AMLODIPINE, CALCICHEW D. Patient died on 07/10/2006.


Mabthera Side Effects Report #5851777-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 05, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, CORTICOSTEROIDS, AMLODIPINE, CALCICHEW D. Patient recovered.

Mabthera Side Effects Report #5914468-2
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 02, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, CORTICOSTEROIDS, AMLODIPINE, CALCICHEW D. Patient recovered.

Mabthera Side Effects Report #5921308-4
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 05, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, CORTICOSTEROIDS, AMLODIPINE, CALCICHEW D. Patient recovered.

Mabthera Side Effects Report #5940854-0
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 20, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, CORTICOSTEROIDS, AMLODIPINE, CALCICHEW D. Patient recovered.

Mabthera Side Effects Report #6133961-3
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 18, 2009. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis What is  osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, CORTICOSTEROIDS, AMLODIPINE, CALCICHEW D. Patient recovered.


Mabthera Side Effects Report #6138395-3
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Mar 16, 2009. Female patient, 84 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 600 MG, 3/WEEK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, ADCAL, PAMIDRONATE DI, ENALAPRIL, ENOXAPARIN. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #5819124-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on July 07, 2008. Female patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: jc virus infection, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, VINBLASTINE SULPHATE. Patient died.

Mabthera Side Effects Report #5835868-5
Mabthera side effect was reported by a Physician from UNITED KINGDOM on July 24, 2008. Female patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, VINBLASTINE SULPHATE. Patient died.

Mabthera Side Effects Report #6132533-4
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Mar 16, 2009. Female patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma, b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy, viral infection What is  viral infection. Mabthera dosage: unknown. During the same period patient was treated with ZEVALIN, YTRACIS. Patient died on 11/24/2008.

Mabthera Side Effects Report #6138354-0
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Mar 16, 2009. Female patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma, b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy, viral infection What is  viral infection. Mabthera dosage: 100 MG, UNK. During the same period patient was treated with ZEVALIN, YTRACIS. Patient died on 11/24/2008.


Mabthera Side Effects Report #6072810-9
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 02, 2009. Male patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-cell lymphoma recurrent, locked-in syndrome, pneumonia What is  pneumonia, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISOLONE, BLEOMYCIN SULPHATE, VINDESINE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #6134187-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 18, 2009. Male patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pneumonia What is  pneumonia, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISOLONE, BLEOMYCIN, VINDESINE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4629460-8
Mabthera side effect was reported by a Physician from on Mar 21, 2005. Male patient, 51 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cd4 lymphocytes decreased, csf culture positive, jc virus infection, progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient died on 11/01/2002.

Mabthera Side Effects Report #4678189-9
Mabthera side effect was reported by a Health Professional from on May 18, 2005. Male patient, 51 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: asthenia, cd4 lymphocytes decreased, progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient died on 11/01/2002.

Mabthera Side Effects Report #5654352-5
Mabthera side effect was reported by a Health Professional from GERMANY on Feb 25, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 700 MG, UNK. Patient was hospitalized. Patient died on 05/10/2007.


Mabthera Side Effects Report #5760198-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 27, 2008. Male patient was diagnosed with non-hodgkin's lymphoma, stem cell transplant and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hemianopia, progressive multifocal leukoencephalopathy, visual field defect. Mabthera dosage: 770 MG, UNK. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Mabthera Side Effects Report #5945664-6
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 24, 2008. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, SOLDESAM. Patient died on 01/27/2008.

Mabthera Side Effects Report #5968583-8
Mabthera side effect was reported by a Health Professional from GERMANY on Nov 12, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: herpes zoster, progressive multifocal leukoencephalopathy. Mabthera dosage: 700 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BENDAMUSTINE, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient was hospitalized. Patient died on 05/10/2007.

Mabthera Side Effects Report #6030523-3
Mabthera side effect was reported by a Health Professional from GERMANY on Dec 18, 2008. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. Patient recovered.

Mabthera Side Effects Report #6092808-4
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Feb 10, 2009. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, Q28D. During the same period patient was treated with BENDAMUSTINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #6130033-9
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Mar 16, 2009. Female patient, 63 years of age, was diagnosed with no therapeutic response, b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: human polyomavirus infection, progressive multifocal leukoencephalopathy, renal failure, viral infection What is  viral infection. Mabthera dosage: 100 MG, UNK. During the same period patient was treated with ZEVALIN. Patient died on 11/24/2008.

Mabthera Side Effects Report #4932238-9
Mabthera side effect was reported by a Physician from FRANCE on Feb 14, 2006. Female patient, 67 years of age, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: mental disorder, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5802379-2
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 23, 2008. Male patient was diagnosed with mantle cell lymphoma, stem cell transplant and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hemianopia, progressive multifocal leukoencephalopathy, visual field defect. Mabthera dosage: 770 MG, UNK. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Mabthera Side Effects Report #5912887-1
Mabthera side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 30, 2008. Male patient was diagnosed with mantle cell lymphoma, stem cell transplant and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hemianopia, progressive multifocal leukoencephalopathy, visual field defect. Mabthera dosage: 770 MG, UNK. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Mabthera Side Effects Report #5949223-0
Mabthera side effect was reported by a Consumer or non-health professional from ITALY on Oct 29, 2008. Male patient was diagnosed with mantle cell lymphoma, stem cell transplant and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hemianopia, progressive multifocal leukoencephalopathy, visual field defect. Mabthera dosage: 770 MG, UNK. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Mabthera Side Effects Report #6013960-2
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Dec 04, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with BENDAMUSTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #6019764-9
Mabthera side effect was reported by a Physician from GERMANY on Dec 16, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with BENDAMUSTINE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, MITOXANTRONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #6134232-1
Mabthera side effect was reported by a Consumer or non-health professional from ITALY on Mar 18, 2009. Male patient was diagnosed with mantle cell lymphoma, stem cell transplant and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hemianopia, progressive multifocal leukoencephalopathy, respiratory failure, visual field defect. Mabthera dosage: 770 MG, UNK. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Mabthera Side Effects Report #5978096-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 18, 2008. Male patient, 78 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, RESPRIMTE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #6023403-0
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 16, 2008. Male patient, 78 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, multi-organ failure, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, RESPRIMTE, OMEPRAZOLE. Patient was hospitalized. Patient died.


Mabthera Side Effects Report #5616040-0
Mabthera side effect was reported by a Health Professional from ITALY on Jan 29, 2008. Male patient, 76 years of age, was diagnosed with diffuse large b-cell lymphoma, anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 650 MG, 1/WEEK. During the same period patient was treated with PREDNISONE, ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5917992-1
Mabthera side effect was reported by a Health Professional from UNITED STATES on Oct 07, 2008. Male patient, 76 years of age, was diagnosed with diffuse large b-cell lymphoma, anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 650 MG, 1/WEEK. During the same period patient was treated with PREDNISONE, ETOPOSIDE, DOXORUBICIN. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #6133957-1
Mabthera side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 18, 2009. Male patient, 76 years of age, was diagnosed with diffuse large b-cell lymphoma, anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 650 MG, 1/WEEK. During the same period patient was treated with PREDNISONE, ETOPOSIDE, DOXORUBICIN. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #5978002-3
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 18, 2008. Female patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy, sinusitis What is  sinusitis. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, IFOSFAMIDE, MESNA, CISPLATIN, STEROID NOS, CARMUSTINE, CYTARABINE, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #5987585-9
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 24, 2008. Female patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy, sinusitis What is  sinusitis. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, IFOSFAMIDE, MESNA, CISPLATIN, STEROID NOS, CARMUSTINE, CYTARABINE, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #5523825-8
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 16, 2007. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died.

Mabthera Side Effects Report #5530964-4
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 16, 2007. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died.

Mabthera Side Effects Report #5579441-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 20, 2007. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #5987741-X
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Nov 25, 2008. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: asthenia, creutzfeldt-jakob disease What is  creutzfeldt-jakob disease, pneumocystis jiroveci pneumonia, progressive multifocal leukoencephalopathy, pyrexia, salmonellosis. Mabthera dosage: 560 MG/M2, UNK. During the same period patient was treated with FLUDARA, DOLASETRON, MEPYRAMINE, PANADO, MEPERIDINE. Patient recovered.

Mabthera Side Effects Report #5616138-7
Mabthera side effect was reported by a Physician from ITALY on Jan 29, 2008. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient recovered.


Mabthera Side Effects Report #5731875-1
Mabthera side effect was reported by a Physician from ITALY on May 02, 2008. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient recovered.

Mabthera Side Effects Report #5917993-3
Mabthera side effect was reported by a Physician from ITALY on Oct 07, 2008. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient died on 06/01/2005.

Mabthera Side Effects Report #6133955-8
Mabthera side effect was reported by a Consumer or non-health professional from ITALY on Mar 18, 2009. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient died on 06/01/2005.

Mabthera Side Effects Report #5616214-9
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 25, 2008. Male patient was diagnosed with b-cell lymphoma, adrenal insufficiency and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hepatitis b antibody positive, progressive multifocal leukoencephalopathy, scrotal infection, septic embolus, tuberculosis What is  tuberculosis. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYTARABINE, CISPLATIN, METHOTREXATE, TRANSFUSION NOS, EPOGEN, HYDROCORTISONE. Patient recovered.

Mabthera Side Effects Report #5919881-5
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Oct 02, 2008. Female patient was diagnosed with b-cell lymphoma, prophylaxis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: balance disorder, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, PEGFILGRASTIM. Patient recovered.

Mabthera Side Effects Report #5960389-9
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Nov 05, 2008. Male patient was diagnosed with b-cell lymphoma, type 2 diabetes mellitus, arterial disorder and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 800 MG, Q3W. During the same period patient was treated with DOXORUBICIN, PREDNISONE, ONCOVIN, ENDOXAN, AMARYL, PLAVIX, CARDIOXANE, NEULASTA. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #6014956-7
Mabthera side effect was reported by a Pharmacist from UNITED KINGDOM on Dec 04, 2008. Female patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-cell lymphoma recurrent, pneumocystis jiroveci pneumonia, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, DOXORUBICIN, PREDNISOLONE, TENIPOSIDE. Patient recovered.

Mabthera Side Effects Report #6016793-6
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Dec 08, 2008. Male patient was diagnosed with b-cell lymphoma, type 2 diabetes mellitus, arterial disorder and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 800 MG, Q3W. During the same period patient was treated with DOXORUBICIN, PREDNISONE, ONCOVIN, ENDOXAN, AMARYL, PLAVIX, CARDIOXANE, NEULASTA. Patient was hospitalized. Patient died on 10/20/2008.

Mabthera Side Effects Report #6019850-3
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Dec 10, 2008. Male patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE, INTERFERON ALPHA, FLUDARABINE PHOSPHATE, MITOXANTRONE. Patient recovered.

Mabthera Side Effects Report #6022221-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Dec 16, 2008. Female patient was diagnosed with b-cell lymphoma, prophylaxis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: balance disorder, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, PEGFILGRASTIM. Patient was hospitalized and became disabled. Patient recovered.


Mabthera Side Effects Report #5616129-6
Mabthera side effect was reported by a Physician from ITALY on Jan 29, 2008. Female patient, 30 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, X2. Patient recovered.

Mabthera Side Effects Report #6004550-6
Mabthera side effect was reported by a Physician from ITALY on Dec 08, 2008. Female patient, 30 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, X2. Patient recovered.

Mabthera Side Effects Report #6133443-9
Mabthera side effect was reported by a Consumer or non-health professional from ITALY on Mar 18, 2009. Female patient, 30 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 375 MG/M2, X2. Patient recovered.

Mabthera Side Effects Report #6123798-3
Mabthera side effect was reported by a Health Professional from UNITED STATES on Mar 17, 2009. Female patient, 45 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. Patient died.

Mabthera Side Effects Report #5102812-8
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Aug 21, 2006. Female patient, 44 years of age, weighting 101.0 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 325 MG/M2, 4/WEEK; INTRAVENOUS. During the same period patient was treated with CIDOFOVIR, FOLIC ACID, HYDROXYCHLOROQUINE, IMMUNE GLOBULIN INTRAVENOUS, LEVOMEPROMAZINE, PROBENECID, LEVOTHYROXINE, IMMUNE GLOBULIN INTRAVENOUS. Patient died on 09/01/2005.

Mabthera Side Effects Report #5172609-1
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Nov 29, 2006. Female patient, 44 years of age, weighting 101.0 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 325 MG/M2, 4/WEEK, INTRAVENOUS. During the same period patient was treated with CIDOFOVIR, FOLIC ACID, HYDROXYCHLOROQUINE, IMMUNE GLOBULIN INTRAVENOUS, LEVOMEPROMAZINE, PROBENECID, LEVOTHYROXINE, IMMUNE GLOBULIN INTRAVENOUS. Patient died on 09/01/2005.

Mabthera Side Effects Report #5397635-9
Mabthera side effect was reported by a Consumer or non-health professional from GERMANY on July 22, 2007. Female patient, weighting 163.1 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, UNK. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, ADALIMUMAB. Patient recovered.

Mabthera Side Effects Report #5398151-0
Mabthera side effect was reported by a Consumer or non-health professional from GERMANY on July 22, 2007. Female patient, weighting 163.1 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: pneumonia What is  pneumonia, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, UNK. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, ADALIMUMAB. Patient died.

Mabthera Side Effects Report #5856558-9
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Aug 12, 2008. Male patient was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, CISPLATIN, CYTARABINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Mabthera